TY - JOUR
T1 - Transcriptional Alterations in X-Linked Dystonia-Parkinsonism Caused by the SVA Retrotransposon
AU - Pozojevic, Jelena
AU - Algodon, Shela Marie
AU - Cruz, Joseph Neos
AU - Trinh, Joanne
AU - Brüggemann, Norbert
AU - Laß, Joshua
AU - Grütz, Karen
AU - Schaake, Susen
AU - Tse, Ronnie
AU - Yumiceba, Veronica
AU - Kruse, Nathalie
AU - Schulz, Kristin
AU - Sreenivasan, Varun K A
AU - Rosales, Raymond L
AU - Jamora, Roland Dominic G
AU - Diesta, Cid Czarina E
AU - Matschke, Jakob
AU - Glatzel, Markus
AU - Seibler, Philip
AU - Händler, Kristian
AU - Rakovic, Aleksandar
AU - Kirchner, Henriette
AU - Spielmann, Malte
AU - Kaiser, Frank J
AU - Klein, Christine
AU - Westenberger, Ana
N1 - Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/2/17
Y1 - 2022/2/17
N2 - X-linked dystonia-parkinsonism (XDP) is a severe neurodegenerative disorder that manifests as adult-onset dystonia combined with parkinsonism. A SINE-VNTR-Alu (SVA) retrotransposon inserted in an intron of the TAF1 gene reduces its expression and alters splicing in XDP patient-derived cells. As a consequence, increased levels of the TAF1 intron retention transcript TAF1-32i can be found in XDP cells as compared to healthy controls. Here, we investigate the sequence of the deep intronic region included in this transcript and show that it is also present in cells from healthy individuals, albeit in lower amounts than in XDP cells, and that it undergoes degradation by nonsense-mediated mRNA decay. Furthermore, we investigate epigenetic marks (e.g., DNA methylation and histone modifications) present in this intronic region and the spanning sequence. Finally, we show that the SVA evinces regulatory potential, as demonstrated by its ability to repress the TAF1 promoter in vitro. Our results enable a better understanding of the disease mechanisms underlying XDP and transcriptional alterations caused by SVA retrotransposons.
AB - X-linked dystonia-parkinsonism (XDP) is a severe neurodegenerative disorder that manifests as adult-onset dystonia combined with parkinsonism. A SINE-VNTR-Alu (SVA) retrotransposon inserted in an intron of the TAF1 gene reduces its expression and alters splicing in XDP patient-derived cells. As a consequence, increased levels of the TAF1 intron retention transcript TAF1-32i can be found in XDP cells as compared to healthy controls. Here, we investigate the sequence of the deep intronic region included in this transcript and show that it is also present in cells from healthy individuals, albeit in lower amounts than in XDP cells, and that it undergoes degradation by nonsense-mediated mRNA decay. Furthermore, we investigate epigenetic marks (e.g., DNA methylation and histone modifications) present in this intronic region and the spanning sequence. Finally, we show that the SVA evinces regulatory potential, as demonstrated by its ability to repress the TAF1 promoter in vitro. Our results enable a better understanding of the disease mechanisms underlying XDP and transcriptional alterations caused by SVA retrotransposons.
UR - http://www.scopus.com/inward/record.url?scp=85124619838&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/595fdc32-fb61-34d6-90da-50ae13ee50de/
U2 - 10.3390/ijms23042231
DO - 10.3390/ijms23042231
M3 - Journal articles
C2 - 35216353
SN - 1661-6596
VL - 23
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 4
M1 - 2231
ER -